Images
The Science Blog “Eduscopi” publishes an interview with ICREA researcher Roger Gomis, leader of the Growth Control and Cancer Metastasis Lab at IRB Barcelona and founder of Inbiomotion, a spin-off of IRB Barcelona and ICREA, launched in 2011.
Roger Gomis set up Inbiomotion with the aim to develop biomarkers to predict bone metastases from biopsies of primary tumors. During the interview, he explains what creating a spin-off is all about, laying special emphasis on social return on investment.
Link to Eduscopi
About IRB Barcelona
The Institute for Research in Biomedicine (IRB Barcelona) pursues a society free of disease. To this end, it conducts multidisciplinary research of excellence to cure cancer and other diseases linked to ageing. It establishes technology transfer agreements with the pharmaceutical industry and major hospitals to bring research results closer to society, and organises a range of science outreach activities to engage the public in an open dialogue. IRB Barcelona is an international centre that hosts 400 researchers and more than 30 nationalities. Recognised as a Severo Ochoa Centre of Excellence since 2011, IRB Barcelona is a CERCA centre and member of the Barcelona Institute of Science and Technology (BIST).
